These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12535733)

  • 1. HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway.
    Yamamoto T; Takeda K; Harada S; Nakata T; Azuma A; Sasaki S; Nakagawa M
    Atherosclerosis; 2003 Feb; 166(2):213-22. PubMed ID: 12535733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells.
    Ito T; Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Shimada K
    Cardiovasc Drugs Ther; 2002 Mar; 16(2):121-6. PubMed ID: 12090904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
    Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K
    J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle.
    Kessler P; Kronemann N; Hecker M; Busse R; Schini-Kerth VB
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):802-10. PubMed ID: 9436821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin upregulates inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells.
    Chen H; Ikeda U; Shimpo M; Ikeda M; Minota S; Shimada K
    Hypertension; 2000 Dec; 36(6):923-8. PubMed ID: 11116101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
    Katsuyama K; Shichiri M; Marumo F; Hirata Y
    Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin.
    Nishikimi T; Tadokoro K; Wang X; Mori Y; Asakawa H; Akimoto K; Yoshihara F; Horio T; Minamino N; Matsuoka H
    Eur J Pharmacol; 2002 Oct; 453(2-3):175-81. PubMed ID: 12398901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
    Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
    Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells.
    Ito T; Ikeda U; Yamamoto K; Shimada K
    Atherosclerosis; 2002 Nov; 165(1):51-5. PubMed ID: 12208470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts.
    Madonna R; Di Napoli P; Massaro M; Grilli A; Felaco M; De Caterina A; Tang D; De Caterina R; Geng YJ
    J Biol Chem; 2005 Apr; 280(14):13503-11. PubMed ID: 15705589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docosahexaenoic acid potentiates interleukin-1beta induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells.
    Hirafuji M; Machida T; Tsunoda M; Miyamoto A; Minami M
    Br J Pharmacol; 2002 Jun; 136(4):613-9. PubMed ID: 12055140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.
    Hattori Y; Nakanishi N; Kasai K
    Cardiovasc Res; 2002 Jun; 54(3):649-58. PubMed ID: 12031711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin increases nitric oxide synthesis in IL-1 beta-stimulated smooth muscle cells.
    Chen H; Xing Y; Liu R
    Chin Med J (Engl); 2001 Nov; 114(11):1123-7. PubMed ID: 11729502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells.
    Shiokoshi T; Ohsaki Y; Kawabe J; Fujino T; Kikuchi K
    J Hypertens; 2002 Mar; 20(3):455-61. PubMed ID: 11875313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins.
    Yang Z; Kozai T; van der Loo B; Viswambharan H; Lachat M; Turina MI; Malinski T; Lüscher TF
    J Am Coll Cardiol; 2000 Nov; 36(5):1691-7. PubMed ID: 11079678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY; Fedtsov A; Madias NE
    Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exaggerated production of nitric oxide (NO) and increases in inducible NO-synthase mRNA levels induced by the pro-inflammatory cytokine interleukin-1beta in vascular smooth muscle cells of elderly rats.
    Chan GH; Fiscus RR
    Exp Gerontol; 2004 Mar; 39(3):387-94. PubMed ID: 15036398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxygenase products regulate nitric oxide and inducible nitric oxide synthase production in interleukin-1beta stimulated vascular smooth muscle cells.
    Hashimoto T; Kihara M; Yokoyama K; Fujita T; Kobayashi S; Matsushita K; Tamura K; Hirawa N; Toya Y; Umemura S
    Hypertens Res; 2003 Feb; 26(2):177-84. PubMed ID: 12627879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K; Hirata Y
    J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.